AGNP Board Exam Question and Answers – Neurology Assessment

$35.00

Category: Tag:

Description

AGNP BOARD EXAM QUESTIONS Neurology Assessment (102 Questions)

  1. Which of the following medications is NOT a serotonin 5-HT1 receptor agonist?
  2. A patient presenting with a transient ischemic attack (TIA) is taking nifedipine (Adalat CC) for hypertension. Pharmacokinetics of nifedipine may be altered in patients with:
  3. Oxcarbazepine (Trileptal) is structurally similar to:
  4. Patients who experience greater than 7 to 9 tension-type headaches per month may be considered for maintenance therapy including:
  5. Beta-blockers, used for the prophylactic treatment of migraines, would NOT be contraindicated in a patient with a history of:
  6. Patients who are taking carbidopa/levodopa (Sinemet) for Parkinson’s disease should be advised to avoid a diet high in:
  7. Which of the following statements is NOT true about antiepileptic drugs (AEDs)
  8. Patients who are taking divalproex sodium (Depakote) and lamotrigine (Lamictal) are at higher risk for developing
  9. Children who are receiving gabapentin (Neurontin) should be monitored for:
  10. During initiation of treatment and escalation of doses, pramipexole (Mirapex) and other dopamine agonists are known to cause:
  11. Sumatriptan (Imitrex), a serotonin (5-HT1) receptor agonist, is:
  12. Patients who require oral corticosteroids for the treatment of Bell’s Palsy should be instructed to take the medication:
  13. To be of greatest benefit, corticosteroids in the treatment of Bell’s palsy should be initiated within:
  14. Beta-blockers are contraindicated in patients with
  15. Ropinirole (Requip), used in the treatment of restless legs syndrome (RLS), is metabolized primarily in the:
  16. Which of the following medications is an N-methyl-D-aspartate receptor antagonist for the treatment of dementia of the Alzheimer’s type?
  17. The most common short-term adverse effects of ropinirole (Requip) used in restless leg syndrome (RLS) include:
  18. Carbidopa/levodopa (Sinemet) for the treatment of Parkinson’s disease is contraindicated in patients with:
  19. Pramipexole (Mirapex), a dopamine agonist, is indicated in the treatment of:
  20. Exercise caution before initiating pregabalin (Lyrica) in combination with:
  21. The first-line treatment in acute tension-type headache i
  22. Triptans, such as sumatriptan (Imitrex), should NOT be administered concomitantly with:
  23. The brand name of oxcarbazepine is:
  24. The first-line pharmacological option for the treatment of generalized tonic-clonic seizures is:
  25. The most common side effects related to benztropine (Cogentin) and trihexyphenidyl, used in the treatment of parkinsonism, are:
  26. Education for patients who are taking amantadine should NOT include:
  27. The generic name for Depakote is:
  28. The primary beta-blocker indicated for the prophylactic treatment of migraine headaches is
  29. A patient who is receiving divalproex sodium (Depakote) reports acute abdominal pain accompanied by nausea and vomiting. This patient should be evaluate for:
  30. At each follow-up visit for patients who are taking carbidopa/levodopa (Sinemet), the provider should specifically inquire about
  31. A patient who is taking beta-blockers for the prophylactic treatment of migraine headache does NOT need to be monitored for:
  32. Macrolides, such as clarithromycin (Biaxin), are NOT generally use to treat:
  33. Amantadine, an antiviral agent and an N-methyl-D-aspartate (NMDA) receptor antagonist, is indicated in the treatment of:
  34. A pediatric patient who is taking valproic acid (Depakene) may exhibit toxicity symptoms which would include:
  35. Phenobarbital, indicate for the treatment of epilepsy, is:
  36. Divalproex sodium (Depakote) for the prophylactic treatment of migraines
  37. The brand name for levetiracetam is
  38. Pregabalin (Lyrica) is NOT approve for the treatment of:
  39. The mechanism of action of pramipexole (Mirapex) is to:
  40. Patients receiving non-cardioselective beta blockers for migraine treatment are much more likely to experience:
  41. Levetiracetam (Keppra), indicated in the adjunctive treatment of partial seizures, is:
  42. Oral levetiracetam (Keppra) is indicate for use as:
  43. Carbidopa/levodopa (Sinemet) for the treatment of Parkinson’s disease is a(n):
  44. The most common reason patients discontinue use of pregabalin (Lyrica) is
  45. Ergotamine alkaloids, such as dihydroergotamine (Migranal), are indicate in the treatment of:
  46. Patients taking topiramate (Topamax) are at high risk for developing:
  47. A patient was start on lamotrigine (Lamictal) 4 weeks ago, and today presents with a mild rash on the upper left thigh. The nurse practitioner should:
  48. Carbamazepine (Tegretol), use in the treatment of trigeminal neuralgia,:
  49. For treatment of Bell’s palsy, combination therapy is consider to be more beneficial and includes corticosteroids plus:
  50. The medication recommend for the rescue of refractory or cluster seizure activity is:
  51. To prevent further events, patients with transient ischemic attacks (TIAs) should be treated with
  52. A patient who is taking valproic acid (Depakote) should have routine laboratory monitoring which includes a:
  53. Serotonin (5HT1) receptor agonists, or triptans:
  54. Primidone (Mysoline) is metabolize into two active metabolites, one of which is:
  55. The brand name for carbamazepine is
  56. A drug interaction may occur between carbamazepine (Tegretol) and:
  57. The brand name of phenytoin sodium is 
  58. The patient who requires the LEAST cautionary measures when treat with carbidopa/levodopa (Sinemet) is:
  59. Ergotamine alkaloids for the treatment of migraines are safe to administer with:
  60. Taking a triptan (5-HT1 agonist), such as sumatriptan (Imitrex), early in the headache cycle does NOT:
  61. Carbidopa and levodopa are the active ingredients in Sinemet use to treat Parkinson’s disease. The addition of carbidopa:
  62. Which medication may be beneficial in the treatment of restless legs syndrome (RLS)?
  63. Ticlopidine (Ticlid), a platelet aggregation inhibitor,
  64. Butalbital, one of the components of Fioricet, a medication used to abort tension-type headaches:
  65. Acetaminophen may be use to reduce fever in the presence of a febrile seizure. A severe complication of acetaminophen (Tylenol) is:
  66. Acute tension-type headaches refractory to simple analgesics may respond to a combination of analgesics and
  67. Which medication does NOT have an indication for the treatment of Parkinson disease?
  68. The medication class that does NOT lead to postural hypotension and possible syncope is:
  69. After initiation of 300 mg serum phenytoin (Dilantin), daily levels should be checked at approximately:
  70. The generic name for Lyrica is
  71. Non-selective beta-blockers used in migraine prophylaxis actively compete for beta receptors, inhibiting the binding of
  72. Benztropine (Cogentin), an anticholinergic, is NOT recommend for use in patients with
  73. A patient who is taking carbamazepine (Tegretol) for trigeminal neuralgia presents with complaints of fatigue, muscle cramps and nausea. These are symptoms of:
  74. Chronic use of phenytoin (Dilantin) has been associate with:
  75. Sumatriptan (Imitrex) is classified as a(n):
  76. Due to increase cholinergic activity in patients treate with donepezil (Aricept), patients should be monitor for:
  77. Patients who are taking rasagiline (Azilect) for the treatment of Parkinson’s disease should avoid other CYP1A2 inhibitors such as:
  78. Patients receive oxcarbazepine (Trileptal) should be routinely monitored for:
  79. Fioricet, indicate for the abortive treatment of tension-type headache, is a combination of acetaminophen,:
  80. Which of the follow is a non-dihydropyridine calcium channel blocker?
  81. Monitoring for side effects of topiramate (Topamax) includes: (AGNP BOARD EXAM QUESTIONS Neurology Assessment)
  82. Patients with mild chronic obstructive pulmonary disease may receive a beta-blocker for migraine prophylaxis as long as they are not currently taking a(n)
  83. Propranolol hydrochloride (Inderal) for the treatment of migraines
  84. A patient receiving lamotrigine (Lamictal) for the treatment of epilepsy would NOT need routine monitoring of:
  85. In addition to the treatment of various forms of epilepsy, lamotrigine (Lamictal) is indicated in the treatment of:
  86. Syncope related to vasovagal symptoms is best treat with:
  87. Common side effects relate to pregabalin (Lyrica) include:
  88. Clopidogrel (Plavix) is consider. (AGNP BOARD EXAM QUESTIONS Neurology Assessment)
  89. Clindamycin (Cleocin) is NOT indicate in the treatment of:
  90. Which medication is approve for prophylactic treatment of migraine headaches
  91. Follow an acute overdose of acetaminophen (Tylenol), patients who are at significant risk for hepatotoxicity should receive:
  92. Monitoring of patients receivegabapentin (Neurontin) should include:
  93. Medications with significant anticholinergic properties, such as amantadine (Symmetrel) to treat Parkinson’s disease, block which neurotransmitter? (AGNP BOARD EXAM QUESTIONS Neurology Assessment)
  94. Donepezil (Aricept), a cholinesterase inhibitor, is indicate in the treatment of
  95. The pharmacological management that provides the greatest clinical improvement of carpal tunnel syndrome is:
  96. Carbamazepine (Tegretol) is indicate in the treatment of:
  97. Divalproex sodium (Depakote) for the treatment of epilepsy can be safely administer to
  98. A medication used in a patient with a transient ischemic attack to prevent platelet aggregation and produce an anti-inflammatory effect in vessels by inhibiting prostaglandin synthesis is:
  99. Topiramate (Topamax), an antiepileptic drug,:
  100. The LEAST important goal of pharmacologic therapy in the treatment of epilepsy is to:
  101. A common adverse reaction to clopidogrel (Plavix) is:
  102. Patients receiving levetiracetam (Keppra) are NOT likely to experience the side effect of:
  103. Check out our latest courses on PSYC 502 Week 3.